Skip to main content

ENTEROVIRUS D68 (EV-D68): UNRAVELING THE MYSTERY

Tracking # 20-476645

$99999.00

4.7 (3 ratings)
Learn more
Educator CEUFAST
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

Enteroviruses alone, excluding the poliovirus, cause about 10 to 15 million infections in the United States each year. Tens of thousands of individuals are hospitalized each year for illnesses caused by enteroviruses. Enterovirus D68 (EV-D68, EV68, HEV68) is a member of the Picornaviridae family, an enterovirus. First isolated in California in 1962 and once considered rare, EV-D68 has been on a worldwide upswing in the 21st century. In 2014, the United States experienced a nationwide outbreak of EV-D68 associated with severe respiratory illness. From mid-August 2014 to January 15, 2015, the CDC or state public health laboratories confirmed 1,153 total cases of respiratory illness caused by EV-D68 in 49 states and the District of Columbia. Almost all of the confirmed cases were among children, many of whom had asthma or a history of wheezing. Additionally, there were likely millions of mild EV-D68 infections for which individuals did not seek medical treatment and/or get tested. The CDC received about 2,600 specimens for enterovirus laboratory testing during 2014, which is substantially more than usual. About 36% of those tested positive for EV-D68. About 33% tested positive for an enterovirus or rhinovirus other than EV-D68. EV-D68 was detected in specimens from 14 patients who died and had samples submitted for testing. State and local officials have the authority to determine and release information about the cause of these deaths. The pain and suffering caused by the enteroviruses and the upsurge specifically in EV-D68 infections has caused the world to pause, backup and investigate retrospectively why this upsurge in activity and how better can we as healthcare providers prevent EV-D68 infections in the future before EV-D68 raises its ugly head again.

Subject areas

This course counts toward the state boards and subject areas below.

Arkansas State Board of Nursing

Certified Nurse Midwife

2h Practice-Focused Continuing Education

Certified Nurse Practitioner

2h Practice-Focused Continuing Education

Certified Registered Nurse Anesthetist

2h Practice-Focused Continuing Education

Clinical Nurse Specialist

2h Practice-Focused Continuing Education

Licensed Practical Nurse

2h Practice-Focused Continuing Education

Licensed Psychiatric Technician Nurse

2h Practice-Focused Continuing Education

Registered Nurse

2h Practice-Focused Continuing Education

Registered Nurse Practitioner

2h Practice-Focused Continuing Education

District of Columbia Board of Nursing

Certified Nurse Midwife

2h Pharmacology Component

Clinical Nurse Specialist

2h Pharmacology Component

Licensed Practical Nurse

2h Licensed Practical Nurse - Continuing Education

Nurse Practitioner

2h Pharmacology Component

Registered Nurse

2h Registered Nurse District of Columbia - Continuing Education

Florida Board of Nursing

Advanced Practice Registered Nurse

2h General

Clinical Nurse Specialist

2h General

Licensed Practical Nurse

2h General

Registered Nurse

2h General

Florida Council of Licensed Midwifery

Licensed Midwife

2h General

Georgia Board of Nursing

Licensed Practical Nurse

2h General

Registered Professional Nurse

2h General

New Mexico Board of Nursing

Certified Nurse Practitioner

2h Continuing education related to pharmacology

Certified Registered Nurse Anesthetist

2h Continuing education related to pharmacology

Clinical Nurse Specialist

2h Continuing education related to pharmacology

Licensed Practical Nurse

2h Continuing education relevant to the licensed practical nurse

Registered Nurse

2h Continuing education relevant to nursing practice

South Carolina Board of Nursing

Advanced Practice Registered Nurse

2h General

Licensed Practical Nurse

2h General

Registered Nurse

2h General

West Virginia Board of Registered Nurses

Advanced Practice Registered Nurse

2h Prescriptive Authority Privilege (RXA) pharmacotherapeutic

Registered Nurse

2h Professional nursing practice and special health care problems

Learner Feedback